Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

Latest News

Moon vows to increase trade with Singapore, Southeast Asia

Jul 15, 2018

SINGAPORE — South Korea's president has pledged to increase trade with Singapore as part of a strategy to raise its economic influence in the region. President Moon Jae-in says the two countries agreed to "invigorate mutual investment" by significantly increasing the trade volume, which is currently at $20 billion. He says: "We will spare no effort to ensure that the companies of our two countries will be able to do joint projects and make joint inroads into third countries together." The push is in line with the country's "New Southern Policy," which aims to strengthen its relationships with the 10-member...

World markets tumble as US, China intensify their trade war

Jul 15, 2018

SINGAPORE — Global stocks tumbled Wednesday after Beijing hit back at U.S. plans for tariffs on $200 billion more Chinese exports, with tensions rising over the trade war between the world's two largest economies. KEEPING SCORE: France's CAC 40 lost 1.2 percent to 5,368 and the FTSE 100 index of British shares dropped 1.2 percent to 7,600. Germany's DAX sank 1.3 percent to 12,440. U.S. indexes are set to open lower after a stretch of gains. Dow futures lost 0.9 percent and the broader S&P 500 futures shed 0.7 percent. ASIA'S DAY: Japan's benchmark Nikkei 225 fell 1.2 percent to...

Malaysia says mastermind behind 1MDB looting fled Macau

Jul 15, 2018

KUALA LUMPUR, Malaysia — Fugitive businessman Low Taek Jho, a suspect in the looting of Malaysian state investment fund 1MDB, has fled Macau to an unknown destination, police said Wednesday. Malaysian authorities have been pursuing Low, known just as Jho Low, since a new government reopened investigations into the scandal. 1MDB was set up by former leader Najib Razak but it accumulated billions in debts and authorities in the U.S., Switzerland and several other countries are investigating. National police chief Mohamad Fuzi Harun said Macau authorities informed him two days ago that Low had fled the territory but didn't say...

Stocks tumble as Asia braces for more US tariffs on China

Jul 15, 2018

SINGAPORE — Asian markets have tumbled after the Trump administration said it was preparing to impose tariffs on another $200 billion of Chinese exports, upping the ante in the trade war between the world's two largest economies. KEEPING SCORE: Japan's benchmark Nikkei 225 fell 0.9 percent to 22,000.81 and South Korea's Kospi lost 0.4 percent to 2,285.34 in morning trading. Hong Kong's Hang Seng shed 1.4 percent to 28,269.72. The Shanghai Composite index tumbled 1.9 percent to 2,774.78. Australia's S&P/ASX 200 dropped 0.6 percent to 6,220.70. Shares also fell in Taiwan and Southeast Asia. WALL STREET: A strong performance by...

Asian markets mirror optimism on Wall Street

Jul 15, 2018

SINGAPORE — Asian markets were mostly higher on Tuesday as overnight gains on Wall Street and the lack of bad news surrounding U.S.-China tariffs boosted sentiment. KEEPING SCORE: Japan's benchmark Nikkei 225 added 1.0 percent in morning trading to 22,278.51 and South Korea's Kospi gained 0.4 percent to 2,295.54. Hong Kong's Hang Seng rose 0.4 percent to 28,796.77, while the Shanghai Composite index was less than 0.1 percent lower at 2,814.00. Australia's S&P/ASX 200 shed 0.3 percent to 6,266.30. Shares were higher in Taiwan and Southeast Asia. WALL STREET: The S&P 500 index rose 0.9 percent on Monday to 2,784.17....

Penggerak pasaran mengikut TradingView

About Us

Duniaga is Malaysia’s top local source for business news and information where people head to stay connected with the business news. We give daily in-depth analysis on the business happenings in the country.

Contact us: sales[at]duniaga.com

Subscribe Now!